-+ 0.00%
-+ 0.00%
-+ 0.00%

XORTX Receives Japanese Patent Allowance for XRx-101 Program

PUBT·11/13/2026 17:01:33
Listen to the news
XORTX Receives Japanese Patent Allowance for XRx-101 Program
  • XORTX Therapeutics received a decision to grant a Japanese patent supporting its XRx-101 program; issuance remains subject to registration.
  • The patent would provide the program’s first protection in Japan, covering compositions targeting acute kidney injury associated with viral infections.
  • Protection is expected to last until March 15, 2041, subject to annuity payments, excluding any potential patent term extension.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. XORTX Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611131200PRIMZONEFULLFEED9877444) on November 13, 2026, and is solely responsible for the information contained therein.